Cite
HARVARD Citation
Welker, J. et al. (2022). Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Lancet infectious diseases. 22 (5), pp. 611-621. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Welker, J. et al. (2022). Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Lancet infectious diseases. 22 (5), pp. 611-621. [Online].